Literature DB >> 8449566

Treatment strategies for Helicobacter pylori infection.

B J Marshall1.   

Abstract

Helicobacter pylori can be eradicated easily in most patients with a 14-day triple-therapy regimen. In patients in whom this treatment fails or who cannot take a full course, other antimicrobial combinations must be considered. This article discusses the various alternatives and explains why various agents should or should not be used. It also includes many new therapies developed in 1992 that allow the physician to treat virtually all H. pylori infections.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8449566

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  10 in total

1.  Current diagnosis and treatment of Helicobacter pylori.

Authors:  A Youssef; Y K Chen
Journal:  West J Med       Date:  1994-03

2.  A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice.

Authors:  J G Fox; P L Gorelick; M C Kullberg; Z Ge; F E Dewhirst; J M Ward
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

4.  Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids.

Authors:  B W Petschow; R P Batema; L L Ford
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

5.  Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; L Yan; B Shames
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country.

Authors:  Javed Yakoob; Wasim Jafri; Shahab Abid; Nadim Jafri; Zaigham Abbas; Saeed Hamid; Muhammad Islam; Kashif Anis; Hasnain Ali Shah; Hizbullah Shaikh
Journal:  BMC Gastroenterol       Date:  2005-11-25       Impact factor: 3.067

8.  Coptisine-induced inhibition of Helicobacter pylori: elucidation of specific mechanisms by probing urease active site and its maturation process.

Authors:  Cailan Li; Ping Huang; Kambo Wong; Yifei Xu; Lihua Tan; Hanbin Chen; Qiang Lu; Chaodan Luo; Chunlai Tam; Lixiang Zhu; Ziren Su; Jianhui Xie
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  The Complete Genome Sequence of the Murine Pathobiont Helicobacter typhlonius.

Authors:  Jeroen Frank; Celia Dingemanse; Arnoud M Schmitz; Rolf H A M Vossen; Gert-Jan B van Ommen; Johan T den Dunnen; Els C Robanus-Maandag; Seyed Yahya Anvar
Journal:  Front Microbiol       Date:  2016-01-08       Impact factor: 5.640

10.  High Effectiveness of a 14-Day Concomitant Therapy for Helicobacter pylori Treatment in Primary Care. An Observational Multicenter Study.

Authors:  Llum Olmedo; Rafael Azagra; Amada Aguyé; Marta Pascual; Xavier Calvet; Emili Gené
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.